2.5 Drug release kinetics measurement To assess the LEV and QS release kinetics, the in vitro release profile of the PEO-CS-LEV/PLGA-QS core-shell nanofibrous mats in PBS (pH 7.4) was fitted into different kinetic models (Fatahi et al., 2021):(Zero order kinetics model)(First order kinetics model)(Higuchi kinetics model)(KorsmeyerPeppas kinetics model) In Eqs 14, f t , t, n and k P represent the fraction of drug released at time t, release time, release exponent, and rate constant, respectively
Key Ingredients: Glutathione
Yu T, Chae M, Wang Z, Ryu G, Kim GB, Lee SY (2025) Microbial technologies enhanced by artificial intelligence for healthcare applications
3.4 Inhibition of intracellular synthesis of reduced glutathione does not impair its extracellular action In the next experiment, buthionine sulfoximine (BSO, 10mM), the inhibitor of -glutamylcysteine synthetase was added during 24 hours to A549 cell culture (Figure 6)
10.1111/j.1365-2982.2009.01334.x 349 YangY.FuA.WuX.ReaganJ
*Correspondence: Mas Rizky A